Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

NCT07351266 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma (Kidney Cancer)

Interventions

DIAGNOSTIC_TEST: Multi-region Tumor Sampling and Integrated Multi-omics Analysis and Microtumor PTC Drug Sensitivity Assay

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences